It is obvious that whether in the training group or the validation group, the level of serum LECT2, APRI, and FIB-4 increased with the aggravation of liver fibrosis (all p < 0.05), and the patients with S4 showed the highest LECT2. This evidence concerns the gene LECT2 and Hepatic fibrosis.